Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqiao Jiedu Pill is a traditional Chinese medicine (TCM) formulation developed and manufactured by Shandong Wohua Pharmaceutical Polytron Technologies. It is based on the classic Yin Qiao San formula, which is a staple in TCM for treating wind-heat type common colds. The preparation is designed to clear heat, detoxify the body, and relieve exterior syndromes. Its primary indications include fever, headache, cough, dry mouth, and sore throat associated with the early stages of febrile diseases. The formula typically comprises a synergistic blend of herbs such as Lonicera japonica (honeysuckle) and Forsythia suspensa, which provide antipyretic and anti-inflammatory properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yinqiao jiedu pill.